Literature DB >> 21720941

Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Ralf Wassmuth1, Hassan Abdel-Aty, Steffen Bohl, Jeanette Schulz-Menger.   

Abstract

OBJECTIVES: Using cardiac magnetic resonance imaging (MRI) we tested the diagnostic value of various markers for amyloid infiltration.
METHODS: We performed MRI at 1.5 T in 36 consecutive patients with cardiac amyloidosis and 48 healthy volunteers. The protocol included cine imaging, T2-weighted spin echo, T1-weighted spin echo before and early after contrast and late gadolinium enhancement. We compared the frequency of abnormalities and their relation to mortality.
RESULTS: Median follow-up was 31 months. Twenty-three patients died. Mean left ventricular (LV) mass was 205 ± 70 g. LV ejection fraction (EF) was 55 ± 12%. T2 ratio was 1.5 ± 0.4. 33/36 patients had pericardial and 22/36 had pleural effusions. All but two had heterogeneous late enhancement. Surviving patients did not differ from those who had died with regard to gender, LV mass or volume. Surviving patients had a significantly higher LVEF (60.4 ± 9.9% vs. 51.6 ± 11.5%; p = 0.03). The deceased patients had a lower T2 ratio than those who survived (1.38 ± 0.42 vs. 1.76 ± 0.17; p = 0.005). Low T2 was associated with shorter survival (Chi-squared 11.3; p < 0.001). Cox regression analysis confirmed T2 ratio < 1.5 as the only independent predictors for survival.
CONCLUSION: Cardiac amyloidosis is associated with hypointense signal on T2-weighted images. A lower T2 ratio was independently associated with shortened survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720941     DOI: 10.1007/s00330-011-2109-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  44 in total

1.  Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy.

Authors:  R Fattori; G Rocchi; F Celletti; P Bertaccini; C Rapezzi; G Gavelli
Journal:  Am Heart J       Date:  1998-11       Impact factor: 4.749

Review 2.  Risk stratification in cardiac amyloidosis: novel approaches.

Authors:  Arnt V Kristen; F Joachim Meyer; Jolanta B Perz; Stefan O Schonland; Michael Hundemer; Ute Hegenbart; Reinhard Singer; Philipp A Schnabel; Falk-Udo Sack; Hartmut Goldschmidt; Hugo A Katus; Thomas J Dengler
Journal:  Transplantation       Date:  2005-09-27       Impact factor: 4.939

3.  Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.

Authors:  E Perugini; C Rapezzi; T Piva; O Leone; L Bacchi-Reggiani; L Riva; F Salvi; L Lovato; A Branzi; R Fattori
Journal:  Heart       Date:  2005-06-06       Impact factor: 5.994

4.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

5.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

Review 6.  Amyloidosis of the heart and respiratory system.

Authors:  Filiep Van Geluwe; Steven Dymarkowski; Ilse Crevits; Walter De Wever; Jan Bogaert
Journal:  Eur Radiol       Date:  2006-05-16       Impact factor: 5.315

7.  Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease.

Authors:  Peter Hunold; Thomas Schlosser; Florian M Vogt; Holger Eggebrecht; Axel Schmermund; Oliver Bruder; Walter O Schüler; Jörg Barkhausen
Journal:  AJR Am J Roentgenol       Date:  2005-05       Impact factor: 3.959

8.  MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis.

Authors:  Waldemar Hosch; Michael Bock; Martin Libicher; Sebastian Ley; Ute Hegenbart; Thomas J Dengler; Hugo A Katus; Hans-Ulrich Kauczor; Günter W Kauffmann; Arnt V Kristen
Journal:  Invest Radiol       Date:  2007-09       Impact factor: 6.016

9.  MRI assessment of cardiac amyloidosis: experience of six cases with review of the current literature.

Authors:  A Seeger; B Klumpp; U Kramer; N I Stauder; M Fenchel; C D Claussen; S Miller
Journal:  Br J Radiol       Date:  2008-11-24       Impact factor: 3.039

10.  Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.

Authors:  Alicia M Maceira; Sanjay K Prasad; Philip N Hawkins; Michael Roughton; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-25       Impact factor: 5.364

View more
  19 in total

1.  Global subendocardial late gadolinium enhancement on cardiac magnetic resonance imaging in severe cardiac AL amyloidosis.

Authors:  Minako Mori; Tomoya Kitagawa; Yuya Sasaki; Takashi Onaka; Akihito Yonezawa; Kazunori Imada
Journal:  Int J Hematol       Date:  2013-01-26       Impact factor: 2.490

2.  How to image cardiac amyloidosis.

Authors:  Rodney H Falk; Candida C Quarta; Sharmila Dorbala
Journal:  Circ Cardiovasc Imaging       Date:  2014-05       Impact factor: 7.792

Review 3.  Impact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathies.

Authors:  Kevin Kalisz; Prabhakar Rajiah
Journal:  World J Cardiol       Date:  2016-02-26

Review 4.  [Hypertrophic and restrictive cardiomyopathy. Differentiation by imaging].

Authors:  S Fritschi; M Prothmann; J Schulz-Menger
Journal:  Herz       Date:  2015-06       Impact factor: 1.443

5.  Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function.

Authors:  Raymond Y Kwong; Bobak Heydari; Siddique Abbasi; Kevin Steel; Mouaz Al-Mallah; Henry Wu; Rodney H Falk
Journal:  Am J Cardiol       Date:  2015-05-22       Impact factor: 2.778

6.  Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy.

Authors:  Tatsuya Nishii; Atsushi K Kono; Mayumi Shigeru; Sachiko Takamine; Sei Fujiwara; Katsusuke Kyotani; Nobukazu Aoyama; Kazuro Sugimura
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-09       Impact factor: 2.357

Review 7.  Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology.

Authors:  Mathew S Maurer
Journal:  Am J Med       Date:  2015-06-17       Impact factor: 4.965

Review 8.  Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.

Authors:  Ralf Wassmuth
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

Review 9.  Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.

Authors:  Wael A Aljaroudi; Milind Y Desai; W H Wilson Tang; Dermot Phelan; Manuel D Cerqueira; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2014-04       Impact factor: 5.952

10.  Clinical and imaging predictors of 1-year and long-term mortality in light chain (AL) amyloidosis: a 5-year follow-up study.

Authors:  Raymond Q Migrino; Leanne Harmann; Richard Christenson; Parameswaran Hari
Journal:  Heart Vessels       Date:  2013-10-19       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.